GI Dynamics (ASX:GID) Change In Receivables : A$0.00 Mil (TTM As of Jun. 2020)

View and export this data going back to 2011. Start your Free Trial

What is GI Dynamics Change In Receivables?

GI Dynamics's change in receivables for the quarter that ended in Jun. 2020 was A$0.00 Mil. It means GI Dynamics's Accounts Receivable stayed the same from Mar. 2020 to Jun. 2020 .

GI Dynamics's change in receivables for the fiscal year that ended in Dec. 2019 was A$0.00 Mil. It means GI Dynamics's Accounts Receivable stayed the same from Dec. 2018 to Dec. 2019 .

GI Dynamics's Accounts Receivable for the quarter that ended in Jun. 2020 was A$0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. GI Dynamics's liquidation value for the three months ended in Jun. 2020 was A$-14.17 Mil.

GI Dynamics Change In Receivables Historical Data

The historical data trend for GI Dynamics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GI Dynamics Change In Receivables Chart

GI Dynamics Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Change In Receivables

Get a 7-Day Free Trial

0.59

0.01

-0.01

0.06

GI Dynamics Quarterly Data
	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

GI Dynamics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was A$0.00 Mil.

GI Dynamics (ASX:GID) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

GI Dynamics's Days Sales Outstanding for the quarter that ended in Jun. 2020 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, GI Dynamics's accounts receivable are only considered to be worth 75% of book value:

GI Dynamics's liquidation value for the quarter that ended in Jun. 2020 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.062	-	15.235	+	0.75 * 0	+	0.5 * 0
=	-14.17

GI Dynamics Change In Receivables Related Terms

Thank you for viewing the detailed overview of GI Dynamics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

GI Dynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GI Dynamics Inc (ASX:GID) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

320 Congress Street, 3rd Floor, Boston, MA, USA, 02210

Website

https://www.gidynamics.com

GI Dynamics Inc is a clinical-stage medical device company. It is engaged in the development and commercialization of EndoBarrier, a medical device indicated for the treatment of patients with type 2 diabetes and obesity. The company is the developer of EndoBarrier, the first endoscopically-delivered device therapy approved for the treatment of obese type 2 diabetic patients. EndoBarrier is the only proven, incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery, without the permanent safety issues associated with gastric bypass. The company generates all of its revenue from sales of its EndoBarrier to health care providers and third-party distributors who resell the product to health care providers.

GI Dynamics Headlines

No Headlines